##Antuna-Puente B, Feve B, Fellahi S, and Bastard JP,(2008). Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 34(1): p. 2-11.## Hajer GR, van Haeften TW, and Visseren FL, (2008). Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 29(24): p. 2959-71.##Kershaw EE and Flier JS, (2004). Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 89(6): p. 2548-2556.## Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, et al., (2006). Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role inmodulating insulin action. Am J Physiol Endocrinol Metab. 290(6): p. E1253-61.## Yang R Xu A, Pray J, Hu H, Jadhao S, Hansen B, Shuldiner A, et al. (2003). Cloning of omentin, a new adipocytokine from omental fat tissue in humans. Diabetes, p. Suppl. 1(1-OR):A1.## De Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al., (2007). Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 56(6): p. 1655-61.## Auguet T, Quintero Y, RiescoD, Morancho B, Terra X, Crescenti A, et al., (2011). New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet. 12: p. 60.## Liu R, Wang X, and Bu P, (2011). Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract. 93(1): p. 21-5.## Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H, et al., (2008). Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes. 57(4): p. 801-8.## Pan HY, Guo L, and Li Q, (2010). Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract. 88(1): p. 29-33.## Moreno-Navarrete JM, Catalan V, Ortega F, Gomez-Ambrosi J, Ricart W, Fruhbeck G, et al., (2010). Circulating omentin concentration increases after weight loss. Nutr Metab (Lond). 7: p. 27.## Venables MC and Jeukendrup AE, (2009). Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Diabetes Metab Res Rev. 25 Suppl 1: p. S18-23.## O'LearyVB, Marchetti CM, Krishnan RK, Stetzer BP, Gonzalez F, and Kirwan JP, (2006). Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol. 100(5): p. 1584-9.## Saremi A, Asghari M, and GhorbaniA, (2010).Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. J Sports Sci. 28(9): p. 993-8.## Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S, et al., (2000). Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet. 67(6): p. 1470-80.## Fu M, Gong DW, Damcott C, Sabra M, Yang RZ, and Pollin TI, (2004). Systematic analysis of omentin 1 and omentin 2 on 1q23 as candidate genes for type 2 diabetes in the old order amish. Diabetes. 53: p. A59.## Tan BK, Pua S, Syed F, Lewandowski KC, O'Hare JP, and Randeva HS, (2008). Decreased plasma omentin-1 levels in Type 1 diabetes mellitus. Diabet Med. 25(10): p. 1254-5.## Cai RC, Wei L, Di JZ, Yu HY, Bao YQ, and Jia WP, (2009).[Expression of omentin in adipose tissues in obese and type 2 diabetic patients]. Zhonghua Yi Xue Za Zhi. 89(6): p. 381-4.## Yan P, Li L, Yang M, Liu D, Liu H, Boden G, et al., (2011). Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 92(3): p. 368-74.## Takala TO, Nuutila P, Knuuti J, Luotolahti M, and Yki-Jarvinen H, (1999).Insulin action on heart and skeletal muscle glucose uptake in weight lifters and endurance athletes. Am J Physiol. 276(4 Pt 1): p.706-11.## DeFronzo RA, Sherwin RS, and Kraemer N, (1987). Effect of physical training on insulin action in obesity. Diabetes. 36(12): p. 1379-85.## Dela F, Mikines KJ, Sonne B, and Galbo H, (1994).Effect of training on interaction between insulin and exercisein human muscle. J Appl Physiol. 76(6): p. 2386-93.## Thorell A, Hirshman MF, Nygren J, Jorfeldt L, Wojtaszewski JF, Dufresne SD, et al., (1999).Exercise and insulin cause GLUT-4 translocation in human skeletal muscle. Am J Physiol. 277(4 Pt 1): p. E733-41.## Hansen PA, Nolte LA, Chen MM, and Holloszy JO, (1998). Increased GLUT-4 translocation mediates enhanced insulin sensitivity of muscle glucose transport after exercise. J Appl Physiol. 85(4): p. 1218-22.## Hayashi T, Hirshman MF, Kurth EJ, Winder WW, and Goodyear LJ, (1998).Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes. 47(8): p. 1369-73.## Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, and Winder WW, (1999).5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes. 48(8): p. 1667-71.## Bai L, Wang Y, Fan J, Chen Y, Ji W, and Qu A, (2007).Dissecting multiple steps of GLUT4 trafficking and identifying the sites of insulin action. Cell Metab. 5: p. 47–57.## DeFronzo RA, (2004). Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 88(4): p. 787-835, ix.##
)